Skip to main content
. 2016 Sep 15;7(42):68442–68448. doi: 10.18632/oncotarget.12035

Table 2. Best response to EGFR TKI therapy.

Response rate (RR) First-line TKI therapy (n = 233) Second-line TKI therapy (n = 169)
Complete response (CR), n (%) 11 (4.7%) 2 (1.2%)
Partial response (PR), n (%) 147 (63.1%) 92 (54.4%)
Stable disease (SD), n (%) 58 (24.9%) 55 (30.8%)
Progressive disease (PD), n (%) 17 (7.3%) 23 (13.6%)
Objective response rate (ORR), n(%) 158 (67.8%) 94 (55.6%)

Abbreviation: TKI, tyrosine kinase inhibitor.